[CTSO] Cytosorbents Corporation

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 5.5 Change: 0.1 (1.85%)

chart CTSO

Refresh chart

Strongest Trends Summary For CTSO

CTSO is in the medium-term down -23% below S&P in 2 months and down -52% below S&P in 7 months. In the long-term up 63% in 4 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -29.46% Sales Growth - Q/Q-17.28% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-82.35% ROE-135.15% ROI
Current Ratio2.4 Quick Ratio2.29 Long Term Debt/Equity Debt Ratio0.64
Gross Margin53.09% Operating Margin-233.51% Net Profit Margin-345.24% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities10.01 M Cash From Investing Activities-1.13 M Cash From Operating Activities-2.41 M Gross Profit420 K
Net Profit-4.72 M Operating Profit-2.71 M Total Assets15.86 M Total Current Assets14.88 M
Total Current Liabilities6.2 M Total Debt Total Liabilities6.2 M Total Revenue720 K
Technical Data
High 52 week14.8 Low 52 week6.82 Last close8.21 Last change-2.61%
RSI59.79 Average true range0.34 Beta1.78 Volume10 K
Simple moving average 20 days3.41% Simple moving average 50 days4.25% Simple moving average 200 days-21.77%
Performance Data
Performance Week-0.85% Performance Month20.38% Performance Quart-15.79% Performance Half-31.01%
Performance Year4.92% Performance Year-to-date1.61% Volatility daily2.5% Volatility weekly5.6%
Volatility monthly11.47% Volatility yearly39.75% Relative Volume219.85% Average Volume176.99 K
New High New Low

News

2019-04-08 05:30:00 | CytoSorbents to Present at the H.C. Wainwright Global Life Sciences Conference 2019 London

2019-03-25 07:10:00 | Israel Approves CytoSorb Registration, CytoSorbents Announces Gad Medical as Distributor

2019-03-11 16:20:00 | CTSO: Q4 2018: Product Sales +27%, Expenses Jump In Part Due to Investments Aimed at Further Accelerating Growth

2019-03-07 22:00:00 | Cytosorbents Corp CTSO Q4 2018 Earnings Conference Call Transcript

2019-03-07 16:15:00 | CytoSorbents Achieves Record Revenue and Product Sales Growth in 2018

2019-03-06 07:00:00 | CytoSorbents to Present at the Cowen 39th Annual Health Care Conference

2019-03-05 07:10:00 | CytoSorbents Expands Direct Sales to Poland, the Nordics, and the Netherlands

2019-02-28 07:00:00 | CytoSorbents to Report Fiscal 2018 Operating and Financial Results

2019-02-25 07:08:00 | CytoSorbents to Participate at the 8th Annual SVB Leerink Global Healthcare Conference

2019-02-05 07:00:00 | CytoSorbents to Present at the 21st Annual BIO CEO & Investor Conference

2019-02-04 15:00:00 | CTSO: DSMB Recommends Continuance of REMOVE Study: Has several important implications

2019-02-04 06:58:00 | CytoSorbents Announces the Data Safety Monitoring Board Recommends Continuation of REMOVE Endocarditis Trial

2019-02-01 11:30:00 | LD Micro Welcomes Nearly 1,000 Companies to the LD Micro Index

2019-01-23 07:45:00 | Detailed Research: Economic Perspectives on Shell Midstream Partners, Interface, National Western Life Group, TPG Specialty Lending, Francesca's, and Cytosorbents — What Drives Growth in Today's Competitive Landscape

2019-01-22 07:08:00 | CytoSorbents Announces Expansion of CytoSorb® Partnership with Fresenius Medical Care

2019-01-18 14:22:59 | Is Cytosorbents Corporation’s NASDAQ:CTSO CEO Pay Fair?

2019-01-07 15:45:00 | CTSO: Q4 / FY 2018: Record Product Sales in Q4, Jumps 51% in 2018

2019-01-07 09:20:00 | CytoSorbents Issues Stockholder Letter with Preliminary 2018 Financial Results

2019-01-04 07:00:00 | CytoSorbents To Highlight Progress at Biotech Showcase 2019

2018-12-21 08:45:00 | CytoSorbents To Receive $619,546 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program

2018-12-10 14:13:26 | Is Cytosorbents Corporation’s NASDAQ:CTSO Balance Sheet Strong Enough To Weather A Storm?

2018-11-26 07:00:00 | CytoSorbents to Present at the 30th Annual Piper Jaffray Healthcare Conference

2018-11-19 07:08:00 | CytoSorbents Recognized Again as One of the Fastest Growing Companies in North America on Deloitte's 2018 Technology Fast 500™

2018-11-12 07:08:00 | CytoSorbents to Present at the Stifel, Jefferies, and Canaccord Investor Conferences This Week

2018-11-09 09:45:00 | CTSO: Q3: Another Solid Quarter. Financials In-Line, REFRESH II Enrollment Accelerating

2018-11-09 08:00:00 | Market Trends Toward New Normal in Paramount Group, Envestnet, Assurant, HubSpot, Epizyme, and Cytosorbents — Emerging Consolidated Expectations, Analyst Ratings

2018-11-06 18:25:34 | CytoSorbents: 3Q Earnings Snapshot

2018-11-06 16:15:00 | CytoSorbents Reports Third Quarter 2018 Financial Results

2018-11-01 14:22:43 | Cytosorbents Corporation NASDAQ:CTSO Is Trading At A 28.36% Discount

2018-10-31 07:00:00 | CytoSorbents to Report Q3 2018 Operating and Financial Results

2018-10-18 09:30:00 | CytoSorbents to Showcase CytoSorb® at Two Key European Medical Conferences

2018-10-15 07:45:00 | Detailed Research: Economic Perspectives on LifePoint Health, Carter's, Lincoln Electric, Cytosorbents, ServiceNow, and Chimera Investment — What Drives Growth in Today's Competitive Landscape

2018-10-03 07:10:00 | CytoSorbents to Present at the Cantor Fitzgerald Global Healthcare Conference

2018-09-20 07:55:00 | CytoSorb® Assigned Dedicated Procedure Code in Switzerland

2018-09-14 11:33:12 | Do You Know Who Else Invests In Cytosorbents Corporation NASDAQ:CTSO?

2018-09-13 07:08:00 | World Sepsis Day 2018: CytoSorbents Sponsors the Sepsis Heroes Gala and the Roger Bone Award for Excellence in Sepsis Research

2018-09-05 09:45:00 | CTSO: FDA Approves REFRESH-2 Protocol Amendment

2018-09-04 07:05:00 | CytoSorbents REFRESH 2-AKI Protocol Amendment Approved by FDA

2018-08-29 18:03:04 | Cytosorbents Stock Could Score Big With Its Blood-Filtering Technology

2018-08-21 09:06:00 | CytoSorbents Awarded up to $3M in SBIR Phase IIB Bridge Funding by NIH/NHLBI to Accelerate U.S. Approval and Commercialization of the HemoDefend™ Blood Transfusion Filter

2018-08-08 12:30:00 | CTSO: Q2 Product Sales Beat Big. New Catalysts Come Online. Moving PT to $15/share

2018-08-08 08:10:00 | Report: Developing Opportunities within Cytosorbents, Nasdaq, Mastercard, Maxim Integrated Products, Bristol-Myers Squibb, and Equity Lifestyle Properties — Future Expectations, Projections Moving into 2018

2018-08-03 05:09:36 | CytoSorbents: 2Q Earnings Snapshot

2018-08-03 01:19:44 | Edited Transcript of CTSO earnings conference call or presentation 2-Aug-18 8:45pm GMT

2018-08-02 16:15:00 | CytoSorbents Achieves Record Total Revenue and CytoSorb Sales in the Second Quarter 2018

2018-08-02 14:45:00 | CytoSorbents Corporation to Host Earnings Call

2018-07-31 07:08:00 | CytoSorbents Expands Distribution of CytoSorb® to a Total of 53 Countries Worldwide

2018-07-26 07:00:00 | CytoSorbents to Report Q2 2018 Operating and Financial Results

2018-07-09 08:00:00 | Aferetica and CytoSorbents Debut the PerLife™ System for Organ Preservation and Rehabilitation at the 27th International Congress of the Transplantation Society

2018-06-26 07:08:00 | CytoSorbents Added to the Russell 2000 and Russell 3000 Indexes